TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CTOR

Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.10$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CTOR
Line item 2022 2023 2024 2025
– – – -4,446.6%
– – +281.5% +11.0%
– +541.0% +3,105.8% -25.1%
– – +0.0% +0.0%
– -98.0% +278.8% +15.0%
– – – -100.0%
– -97.5% +192.7% +211.2%
– -188.7% – –
– – – -4,446.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?